Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.40p
   
  • Change Today:
      0.20p
  • 52 Week High: 12.20
  • 52 Week Low: 2.26
  • Currency: UK Pounds
  • Shares Issued: 1,068.42m
  • Volume: 180,093
  • Market Cap: £100.43m
  • Beta: 0.03
Select chart: 3 month | 6 month | 1 year
 

3 month

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 76.40 2.63 (0.15)p n/a n/a -90% n/a 0.0%
31-Dec-27 107.65 20.20 1.04p 8.9 n/a n/a n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
31-Dec-2026 n/a n/a n/a 76 81 64
31-Dec-2027 n/a n/a n/a 108 124 n/a
 
Earnings
31-Dec-2026 n/a n/a n/a n/a n/a n/a
31-Dec-2027 n/a n/a n/a 0.93p 1.68p n/a
 
Dividend
31-Dec-2026 n/a n/a n/a n/a n/a n/a
31-Dec-2027 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 0 0 0 1 0 1
Buy 0 0 0 1 0 0
Neutral 0 0 0 0 0 1
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 0 0 0 2 0 2
 
Average Rec n/a n/a n/a 8.75 n/a 7.50

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

STX Market Data

Currency UK Pounds
Share Price 9.40p
Change Today 0.20p
% Change 2.17 %
52 Week High 12.20
52 Week Low 2.26
Volume 180,093
Shares Issued 1,068.42m
Market Cap £100.43m
Beta 0.03

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average
70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average
Price Trend
58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average
77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average
Income Not Available
Growth
64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average
79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 17-Apr-2026

Time Volume / Share Price
11:45 33,818 @ 9.25p
11:19 54,318 @ 9.22p
10:02 15,000 @ 9.20p
10:01 2,585 @ 9.22p
09:44 110 @ 9.21p

STX Key Personnel

CEO Anders Lundstrom

Top of Page